INDAZOLE

Patent europeic · EP3183239 · En vigur

Inscripziun en il register

Numer da publicaziun
EP3183239
Numer da la dumonda
EP15744882
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
30-07-2015
Publitgà
28-06-2017
Concedì
26-09-2018
La protecziun finescha il pli tard
29-07-2035
Proxima taxa annuala scadenta
31-07-2027
Classas IPC
C07D 231/56 (2006.01)
C07D 471/04 (2006.01)
A61K 31/416 (2006.01)
A61K 31/437 (2006.01)
A61P 35/00 (2006.01)
Prioritad
EP 14002929 22.08.2014
Dumonda PCT
PCT/EP2015/001570 30.07.2015
Publicaziun PCT
WO2016/026549 25.02.2016
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 20-08-2026

    Next annual fee due on

    Next annual fee due on
    31.07.2026 → 31.07.2027

    Published in Swissreg on 20.08.2026

  2. 08-08-2025

    Next annual fee due on

    Next annual fee due on
    31.07.2025 → 31.07.2026

    Published in Swissreg on 08.08.2025

  3. 20-08-2024

    Midada

    Published in Swissreg on 20.08.2024

  4. 28-03-2024

    Cuntinuaziun da la procedura dumandada

    Published in Swissreg on 28.03.2024

  5. 28-03-2024

    Midada

    Published in Swissreg on 28.03.2024

  6. 23-02-2024

    Stritgà, taxa betg pajada

    Published in Swissreg on 23.02.2024

  7. 01-08-2022

    Midada

    Published in Swissreg on 01.08.2022

  8. 26-09-2018

    Concedì

    Published in Swissreg on 26.09.2018

Partidas

Possessur

Cancer Research Technology Ltd.

London EC1V 4AD, GB

Merck Patent GmbH

64293 Darmstadt, DE

Inventur

SCHIEMANN, Kai

64342 Seeheim-Jugenheim, DE

MALLINGER, Aurélie

F-54800 Affleville, FR

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.